Listing 3 - Actual negotiations

Indication:

Transfusional iron overload due to sickle cell disease or other anemias

Indication:

Systemic lupus erythematosus

Indication:

Unresectable or metastatic uveal melanoma in adult patients who are Human leukocyte antigen (HLA)-A*02:01-positive

Indication:

Unresectable or metastatic, well-differentiated, somatostatin receptor (SSR)-positive pancreatic neuroendocrine tumours (pNETs) in adults whose disease has progressed after treatment with a somatostatin analogue (SSA), unless there is a contraindication or intolerance

Indication:

Episodic migraine in adults (prevention)

Indication:

Atypical hemolytic uremic syndrome

Indication:

Paroxysmal nocturnal hemoglobinuria (PNH)

Indication:

Diabetes mellitus in patients who require insulin for the control of hyperglycemia (normally to be used in regimens together with an intermediate or long-acting insulin), or continuous subcutaneous insulin infusion (CSII) in pump systems which are licensed in Canada for Trurapi insulin infusion

Indication:

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Indication:

Ankylosing Spondylitis, Plaque Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis and Polyarticular Juvenile Idiopathic Arthritis